Impact of heavy smoking on the benefits from first-line EGFR-TKI therapy in patients with advanced lung adenocarcinoma

Smoking is a risk factor for nonsmall cell lung carcinoma (NSCLC) and is associated with a lower response to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI). The purpose of this study is to examine the impact of the smoking status on the benefits from first-line EGFR-TKI in NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ping, Nie, Xin, Bie, Zhixin, Li, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851738/
https://www.ncbi.nlm.nih.gov/pubmed/29489642
http://dx.doi.org/10.1097/MD.0000000000010006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851738/
https://www.ncbi.nlm.nih.gov/pubmed/29489642
http://dx.doi.org/10.1097/MD.0000000000010006

Ejemplares similares